Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 715-719

  Canut, M I ^a   Alvarez, A ^b   Nadal, J ^b   Abreu, R ^c   Abreu, J A ^d   Pulido, J S ^e  

^a Glaucoma section   (Spain)

^b INSTITUT UNIVERSITARI BARRAQUER   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^d HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^e MAYO CLINIC   (United States)

Author keywords

Angle closure; Avastin ; Bevacizumab; Complications; Glaucoma; Intravitreal; Neovascular; Rubeosis

Indexed keywords

BEVACIZUMAB;

ADULT; AGED; ANTERIOR EYE CHAMBER ANGLE; ANTERIOR EYE SEGMENT; ARTICLE; CLINICAL ARTICLE; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; IRIS RUBEOSIS; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); OPEN ANGLE GLAUCOMA; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TRABECULOTOMY;

EID: 79958797680     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S17350     Document Type: Article

References (22)

1. Brown GC, Magargal LE, Schachat, et al. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 1984;91(4):315-320.
2. Allingham RA, Damji K F, Freedman S, et al, editors. Glaucomas associated with disorders of the retina, vitreous and choroids. Shields ́ Textbook of Glaucoma. 5th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2005.
3. ®) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142(6):1054-1056.
4. Mason JO, Albert MA, Mays A, Vail R. Regression of neovascu-lar iris vessels by intravitreal injection of bevacizumab. Retina. 2006; 26(7):839-841.
5. ®) on anterior segment neovascularization in neovascular glaucoma. Acta Ophthalmol Scand. 2006;84(4):556-557.
6. Ghanem AA, El-Kannishy AM, El-Wehidy AS, et al. Intravitreal bevacizumab (Avastin) as an adjuvant treatment in cases of neovascular glaucoma. Middle East Afr J Ophthalmol. 2009;16(2):75-79.
7. Douat J, Auriol S, Mahieu-Durringer L, et al. Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases. J Fr Ophtalmol. 2009;32(9):652-663. French.
8. Ciftci S, Sakalar YB, Unlu K, et al. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma. Eur J Ophthalmol. 2009;19(6):1028-1033.
9. Yazdani S, Hendi K, Pakravan M, et al. Intravitreal bevacizumab for neovascular glaucoma: A randomized controlled trial. J Glaucoma. 2009;18(8):632-637.
10. Hasanreisoglu M, Weinberger D, Mimouni K, et al. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma. Eur J Ophthalmol. 2009;19(4):607-612.
11. Duch S, Buchacra O, Milla E, et al. Intracameral bevacizumab (Avastin) for neovascular glaucoma: A pilot study in 6 patients. J Glaucoma. 2009;18(2):140-143.
12. Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115(9):1571-1580.
13. ®) injection. Retina. 2006; 26(3):354-356.
14. Grisanti S, Biester S, Peters S, Tatar O, Ziemssen F, Bartz-Schmidt KU; Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis. Am J Ophthalmol. 2006;142(1):158-160.
15. Kahook MY, Schuman JS, Noecker RJ. Intravitreal bevacizumab in a patient with neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2006;37(2):144-146.
16. Sugimoto Y, Mochizuki H, Okumichi H, et al. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2010;248(11):1601-1609.
17. Semoun O, Blumen-Ohana E, de Preobrajensky N, et al. Acute angle-closure glaucoma complicating an intravitreal injection of bevacizumab. J Fr Ophtalmol. 2009;32(1):58.e1-e4. French.
18. Moraczewski AL, Lee RK, Palmberg P F, et al. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93(5):589-593.
19. Alkawas AA, Shahien EA, Hussein AM. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C. J Glaucoma. 2010; 19(9):622-626.
20. Saito Y, Higashide T, Takeda H, et al. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab. Am J Ophthalmol. 2010;149(6): 964-972.e1.
21. Vasudev D, Blair M P, Galasso J, et al. Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009;25(5):453-458.
22. Lupinacci A P, Calzada JI, Rafeetery M, et al. Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab. Adv Ther. 2009;26(2):208-216.